2-o sulfatase compositions and related methods
CA 2512673 C · Owner: Massachusetts Institute Of Technology · Inventors: Shriver, Zachary; Sasisekharan, Ram; Myette, James R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to 2-O sulfatase and uses thereof. In particular the , invention relates to recombinantly produced 2-O sulfatase functional variants , and nucleic acid molecules that encode these molecules. The invention also provides methods of using 2-O sulfatase for a variety of purposes including , degrading and analyzing glycosaminoglycans (GAGS) present in a sample. For instance, 2-O sulfatase may be used for determining the purity identity, composition and sequence of glycosaminoglycans present in a sample. The invention also relates to methods of inhibiting angiogenesis and cellular proliferation as well as methods for treating cancer neurodegenerative , disease, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 7, 2004 and granted November 5, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 7, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 7, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.